KRAS (Kirsten rat sarcoma virus) is an oncogene that is mutated in about 25% of all cancers, but it only recently became a promising therapeutic target for anti-cancer therapy because of significant scientific breakthroughs (Figure 8) (1, 53, 55). The gene discussed is KRAS; the disease is cancer.